12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Fri, 26 Jun 2026 11:28:37 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6IkljVklPb1FvTjNIYXFaY3FLMlVVNWc9PSIsInZhbHVlIjoiNU9veTQrWms4R2NDaThWODB5MVg2NVlBcjRzT04wMW5tZGx0XC9Xa0VKZGJKaHNSZDA1YXRNZ092Wmt6MEN6RFYyRTZJcHJwR09IWnR5NHVwXC81OTlXdz09IiwibWFjIjoiN2RmZjU3MTllZTc0MzFiZGQxNDg2M2RkN2ExMGNjMzUzM2U3NzYwZDBlMzZkMjQzMjhjYTM4MTUyZTE5YTk5YSJ9; expires=Mon, 25-Jun-2029 11:28:36 GMT; Max-Age=94608000; path=/; HttpOnly [7] => X-Frame-Options: SAMEORIGIN [8] => X-Content-Type-Options: nosniff [9] => X-Xss-Protection: 1; mode=block [10] => Referrer-Policy: strict-origin-when-cross-origin [11] => Permissions-Policy: geolocation=(), microphone=(), camera=() [12] => Content-Security-Policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => X-Robots-Tag: noindex, nofollow, nosnippet, noarchive [15] => Strict-Transport-Security: max-age=31536000; includeSubDomains; preload [16] => Expires: Sat, 27 Jun 2026 11:28:36 GMT [17] => Vary: Accept-Encoding [18] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [19] => Cf-Cache-Status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=18,cfOrigin;dur=111 [23] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=EGWvNS9%2F%2FAyWj78TWd826zm5FSCh4QjrQL3bqkm227NwE06p6wfwqiUB%2BW0m6lCmgRM%2FHWFref5CqIyCHMLR8u3xxVUVe2VosX%2Bo84EaPYawGpfa00yfHV0lTVjKgGjpB8g%3D"}]} [24] => CF-RAY: a11bde974f2a6596-SIN [25] => alt-svc: h3=":443"; ma=86400 ) 789

（吉隆坡13日讯）卫生部不曾通过药物管理局（PBKD）批准任何宣称能治疗和预防骨痛热症、寨卡和基孔肯雅症的草药产品。

卫生总监拿督诺希山医生说，卫生部接获投诉有关该草药产品通过社交媒体刊登广告，声称能治疗和预防骨痛热症。

他今天发文告说，所有向药物管理局注册的产品，其广告必须获得药物广告局的批准，才能向公众传播。

“未经药物广告局批准刊登广告，可在1956年药物（广告及销售）法令下被采取法律行动。一旦罪成，有关人士或公司可被罚款不超过3000令吉或坐牢不超过1年，或两者兼施。”

卫生部劝请民众采取骨痛热症预防措施，同时若出现骨痛热症症状如发烧、头痛、关节疼痛、红疹、想吐、呕吐，或早期状况如持续呕吐、腹痛或疲累，就须尽速求医。

民众可将可疑的药物产品资料提供给国家药剂监管局（NRPA）https://www.npra.gov.my/index.php/public-enquiry-complaints/contactus或致电03-7883 5400，或发送电邮至npra@npra.gov.my。

---

// // // //